| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4864 | 2018 |
| The Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. A al Cell 161, 1681-1696, 2015 | 2831* | 2015 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1935* | 2020 |
| Whole-genome landscapes of major melanoma subtypes NK Hayward, JS Wilmott, N Waddell, PA Johansson, MA Field, K Nones, ... Nature 545 (7653), 175-180, 2017 | 1393 | 2017 |
| Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled … V Galimberti, BF Cole, G Viale, P Veronesi, E Vicini, M Intra, G Mazzarol, ... The Lancet Oncology 19 (10), 1385-1393, 2018 | 481 | 2018 |
| Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2 … EA Rozeman, AM Menzies, ACJ van Akkooi, C Adhikari, C Bierman, ... The Lancet Oncology 20 (7), 948-960, 2019 | 469 | 2019 |
| Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment AJ Spillane, R A’Hern, IR Judson, C Fisher, JM Thomas Journal of clinical oncology 18 (22), 3794-3803, 2000 | 465 | 2000 |
| Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC) AM Menzies, RN Amaria, EA Rozeman, AC Huang, MT Tetzlaff, ... Nature medicine 27 (2), 301-309, 2021 | 371 | 2021 |
| Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets F Newell, Y Kong, JS Wilmott, PA Johansson, PM Ferguson, C Cui, Z Li, ... Nature communications 10 (1), 3163, 2019 | 276 | 2019 |
| Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma EA Rozeman, EP Hoefsmit, ILM Reijers, RPM Saw, JM Versluis, ... Nature medicine 27 (2), 256-263, 2021 | 271 | 2021 |
| Survivorship care plans in cancer: a systematic review of care plan outcomes ME Brennan, JF Gormally, P Butow, FM Boyle, AJ Spillane British journal of cancer 111 (10), 1899-1908, 2014 | 245 | 2014 |
| Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium RN Amaria, AM Menzies, EM Burton, RA Scolyer, MT Tetzlaff, ... The Lancet Oncology 20 (7), e378-e389, 2019 | 220 | 2019 |
| Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial ILM Reijers, AM Menzies, ACJ Van Akkooi, JM Versluis, ... Nature medicine 28 (6), 1178-1188, 2022 | 213 | 2022 |
| Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors I Hoeber, AJ Spillane, C Fisher, JM Thomas Annals of surgical oncology 8, 80-87, 2001 | 192 | 2001 |
| Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma MT Tetzlaff, JL Messina, JE Stein, X Xu, RN Amaria, CU Blank, ... Annals of Oncology 29 (8), 1861-1868, 2018 | 190 | 2018 |
| Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement J Crosbie, SL Kilbreath, E Dylke, KM Refshauge, LL Nicholson, JM Beith, ... Physical therapy 90 (5), 679-692, 2010 | 183 | 2010 |
| Epithelioid sarcoma: the clinicopathological complexities of this rare soft tissue sarcoma AJ Spillane, J Meirion Thomas, C Fisher Annals of Surgical Oncology 7, 218-225, 2000 | 180 | 2000 |
| Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial GV Long, RPM Saw, S Lo, OE Nieweg, KF Shannon, M Gonzalez, ... The Lancet Oncology 20 (7), 961-971, 2019 | 171 | 2019 |
| In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy RL Read, L Haydu, RPM Saw, MJ Quinn, K Shannon, AJ Spillane, ... Annals of surgical oncology 22, 475-481, 2015 | 165 | 2015 |
| Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells PS Soon, E Kim, CK Pon, AJ Gill, K Moore, AJ Spillane, DE Benn, ... Endocr Relat Cancer 20 (1), 1-12, 2013 | 161 | 2013 |
